VIVO
$14.84
Meridian Bioscience
($.21)
(1.40%)
VIVO
Earnings Whisper ®
N/A
3rd Quarter June 2020
Consensus:  $0.06
Revenue:  $48.63 Mil
Friday
Aug 7
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when VIVO reports earnings?
Beat
Meet
Miss

Where is VIVO's stock price going from here?
Up
Flat
Down
Stock chart of VIVO
Analysts
Summary of analysts' recommendations for VIVO
Score
Grade
Pivots
Resistance
$16.00
$15.72
$15.28

$15.01

Support
$14.57
$14.29
$13.85
Tweet
Growth
Description
Meridian is a fully integrated life sciences company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections.
Peers
ImmunomedicsMyriad GeneticsQuidelCareDxSurModics